Page last updated: 2024-09-04

fce 28260 and dihydrotestosterone

fce 28260 has been researched along with dihydrotestosterone in 1 studies

Compound Research Comparison

Studies
(fce 28260)
Trials
(fce 28260)
Recent Studies (post-2010)
(fce 28260)
Studies
(dihydrotestosterone)
Trials
(dihydrotestosterone)
Recent Studies (post-2010) (dihydrotestosterone)
6019,3253071,517

Protein Interaction Comparison

ProteinTaxonomyfce 28260 (IC50)dihydrotestosterone (IC50)
Plasma kallikreinHomo sapiens (human)0.0031
Glucocorticoid receptorHomo sapiens (human)0.54
Sex hormone-binding globulinHomo sapiens (human)0.0038
Progesterone receptorOryctolagus cuniculus (rabbit)0.44
Progesterone receptorHomo sapiens (human)7.3
Mineralocorticoid receptor Homo sapiens (human)0.36
Sex hormone-binding globulinRattus norvegicus (Norway rat)0.023
Androgen receptorHomo sapiens (human)0.0048
Androgen receptorRattus norvegicus (Norway rat)0.4041
Androgen receptorMus musculus (house mouse)0.001
Mineralocorticoid receptorRattus norvegicus (Norway rat)2.1
Testosterone 17-beta-dehydrogenase 3Homo sapiens (human)0.0026

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briatico, G; Cominato, C; di Salle, E; Giudici, D; Iehlè, C; Nesi, M; Panzeri, A; Zaccheo, T1

Other Studies

1 other study(ies) available for fce 28260 and dihydrotestosterone

ArticleYear
FCE 28260, a new 5 alpha-reductase inhibitor: in vitro and in vivo effects.
    The Journal of steroid biochemistry and molecular biology, 1996, Volume: 58, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Androstenes; Animals; Azasteroids; Dihydrotestosterone; Enzyme Inhibitors; Humans; Male; Prostate; Rats

1996